APS improve ER and the resulting autophagy by inhibiting the ATF6 passage and glucose-regulated protein 78 (GRP78)-related pathways [including IRE-1, the c-Jun N-terminal kinase (JNK), and PERK], reducing the apoptosis factors expression of C/EBP-homologous protein and caspase-12 (Wang et al., 2009
PK Assessments Blood samples for PK assessment of semaglutide were taken at the following time points after the first dose: 0, 6, 12, 18, 24, 30, 36, 42, 48, 60, 72, 84, 96, 120, 144 and 168 h and at the following time points after the last dose: 0, 6, 12, 18, 24, 30, 36, 42, 48, 60, 72, 84, 96, 120, 144, 168, 336, 504, 672 and 840 h
Abdelrazik H, Agarwal A
Side effects: rare
Sharma AX, Quittner-Strom EB, Lee Y et al (2018) Glucagon receptor antagonism improves glucose metabolism and cardiac function by promoting AMP-mediated protein kinase in diabetic mice